The UK Health Security Agency (UKHSA) said the new case - the sixth detected in the UK since October last year - was in a ...

"SIGA’s antiviral approved in Japan for orthopoxvirus treatment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

( MENAFN - IANS) Nairobi, Jan 17 (IANS) Kenya's Ministry of health on Friday confirmed two more cases of monkeypox, raising ...

Zambia has confirmed three new monkeypox cases, bringing the total number to seven, authorities said.Minister of <a target= ...

After the fast spread of HMPV cases in China, a new strain of Mpox-Clade 1b- has surfaced. Apart from fatigue and fever, it ...

Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus, a species of the genus Orthopoxvirus. There are two distinct clades of the virus: clade I (with subclades Ia ...

NV-387 was found to be equivalent or superior to tecovirimat in lethal orthopoxvirus infection animal models. We believe these data should enable Phase II clinical trial of NV-387 for the treatment of ...

SIGA Technologies has gained Japanese regulatory approval for TEPOXX (tecovirimat) 200mg capsules, known as TPOXX in the US, for the treatment of smallpox, mpox and cowpox, and complications following ...

"The approval of TEPOXX in Japan marks another significant milestone in our mission to expand access to this critical antiviral treatment worldwide to support an effective response to an orthopoxvirus ...